Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
暂无分享,去创建一个
M. Price | M. Hutyra | D. Holmes | G. Montalescot | D. Angiolillo | S. Manoukian | C. Dyke | M. Firstenberg | J. Prats | I. Welsby | Tiepu Liu | M. Brtko | N. Chronos | L. Cannon | Michele Voeltz | M. Dietrich | P. Tummala | M. Todd | H. Chandna | Chandrashekar Ramaiahm | Eric J Topo